Biogen (Netherlands)

Basic Information

• Category: business
• Website: https://www.biogen.nl/

Documented Facts

• Inception (Wikidata): 1978 (Source 4: Wikidata Q30268762, revision 2474424946)
• Country (Wikidata; date unspecified): Netherlands (Source 4: Wikidata Q30268762, revision 2474424946; Source 5: Wikidata label: Q55, revision 2556226405)
• Official website (Wikidata; date unspecified): https://www.biogen.nl/ (Source 4: Wikidata Q30268762, revision 2474424946)

Evidence and Sources

• Biogen (Netherlands) — Official Site (official)
• Biogen (Netherlands) on facebook (social)
• Biogen (Netherlands) on linkedin (social)
• Wikidata Q30268762, revision 2474424946 (knowledge-base)
• Wikidata label: Q55, revision 2556226405 (knowledge-base)

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Biogen (Netherlands).

• Canonical profile: https://brandsource.ai/brands/biogen-netherlands
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/biogen-netherlands/json-ld
• Citation profile API: https://brandsource.ai/api/brands/biogen-netherlands/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (91/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-22

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Is een in 1978 opgericht toonaangevend wereldwijd biotechnologiebedrijf. Biogen heeft belangrijk pionierswerk verricht, met onder meer een uitgebreid portfolio aan geneesmiddelen voor de behandeling van multipele sclerose, de eerste goedgekeurde behandeling voor spinale musculaire atrofie en de co-ontwikkeling van twee behandelingen gericht op een bepalende pathologie van de ziekte van Alzheimer.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 4 supporting sources linked.
• 3 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.